Khuanchai Supparatpinyo

Suggest Changes
Learn More
BACKGROUND Pooled analysis of phase 3, double-blind, double-dummy ECHO and THRIVE trials comparing rilpivirine (TMC278) and efavirenz. METHODS Treatment-naive HIV-1-infected adults were randomized(More)
The prevalence of drug resistance was determined among 64 HIV-infected Thai patients who were failed while receiving nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens. Eighty-nine(More)